Fresenius Medical Care
Financials
2022 Annual Revenue
€19.40 Billion
2022 Annual Gross Profit
€5.31 Billion
2022 Annual Net Income
€895 Million
2022 Annula Revenue Growth
10.10%
2022 Number of Employees
4,116
Credit Rating
Moody's Rated: Investment Grade Baa3 (Long-Term)
Fresenius Medical Care
Fresenius Medical Care (NYSE: FMS) provides dialysis related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates 4,116 dialysis centers in North America and has over 128,000 employees. These facilities routinely provide medically necessary renal care to hundreds of thousands of patients with chronic kidney failure.